Resoconti Nabriva Therapeutics plc

Azioni

NBRVF

IE000OZRGNV6

Mercato chiuso - OTC Markets Altri mercati azionari 21:14:56 09/07/2024			Variaz. 5gg	Var. 1 gen.
0,0001 ^USD	0,00%		0,00%	+9.900,00%

2023	Nabriva Therapeutics plc riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 30 giugno 2023	CI
2023	Sumitomo Pharma Co., Ltd. (TSE:4506) ha acquisito le attività e i diritti relativi alla lefamulina in Cina, Hong Kong, Macao e Taiwan da Nabriva Therapeutics plc (OTCPK:NBRV.F), Nabriva Therapeutics US, Inc, Nabriva Therapeutics GmbH e Nabriva Therapeutics Ireland Dac per 15 milioni di dollari.	CI

Resoconti

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Transcript : Nabriva Therapeutics plc, Q3 2022 Earnings Call, Nov 10, 2022	10/11/22
Transcript : Nabriva Therapeutics plc, Q2 2022 Earnings Call, Aug 03, 2022	03/08/22
Transcript : Nabriva Therapeutics plc, Q1 2022 Earnings Call, May 05, 2022	05/05/22
Transcript : Nabriva Therapeutics plc, Q4 2021 Earnings Call, Mar 29, 2022	29/03/22
Nabriva Therapeutics plc fornisce una previsione delle entrate per il quarto trimestre del 2021	10/01/22	CI
Transcript : Nabriva Therapeutics plc, Q3 2021 Earnings Call, Nov 09, 2021	09/11/21
Transcript : Nabriva Therapeutics plc, Q2 2021 Earnings Call, Aug 05, 2021	05/08/21
Transcript : Nabriva Therapeutics plc, Q1 2021 Earnings Call, May 06, 2021	06/05/21
Transcript : Nabriva Therapeutics plc, Q4 2020 Earnings Call, Mar 11, 2021	11/03/21
Transcript : Nabriva Therapeutics plc, Q3 2020 Earnings Call, Nov 05, 2020	05/11/20
Transcript : Nabriva Therapeutics plc, Q2 2020 Earnings Call, Aug 06, 2020	06/08/20
Transcript : Nabriva Therapeutics plc Presents at BofA Securities 2020 Health Care Conference, May-13-2020 11:00 AM	13/05/20
Transcript : Nabriva Therapeutics plc, Q1 2020 Earnings Call, May 11, 2020	11/05/20
Transcript : Nabriva Therapeutics plc, Q4 2019 Earnings Call, Mar 12, 2020	12/03/20
Transcript : Nabriva Therapeutics plc, Q3 2019 Earnings Call, Nov 12, 2019	12/11/19
Transcript : Nabriva Therapeutics plc Presents at Morgan Stanley 17th Annual Global Healthcare Conference, Sep-09-2019 09:55 AM	09/09/19
Transcript : Nabriva Therapeutics plc - Special Call	19/08/19
Transcript : Nabriva Therapeutics plc Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-15-2019 04:20 PM	16/05/19
Transcript : Nabriva Therapeutics plc - Special Call	01/05/19
Transcript : Nabriva Therapeutics plc - Analyst/Investor Day	23/01/19

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Resoconti Nabriva Therapeutics plc

Azioni

NBRVF

IE000OZRGNV6

Resoconti

Filtri